Evidence map›Paper›PMID 41989463›Full record

ReviewAdvances in biochemical engineering/biotechnology2026

Perspectives Towards AI and ML.

Guoquan Wu, Zhe Wu

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Guoquan WuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore. wu.guoquan@u.nus.edu.ORCID https://orcid.org/0000-0002-0643-2854
Zhe WuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore. wuzhe@nus.edu.sg.ORCID https://orcid.org/0000-0002-2923-149X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This chapter discusses the applications of artificial intelligence (AI) machine learning (ML) to address the practical challenges in biomolecular crystallization processes. Although AI and ML techniques have been successfully applied in many scientific domains, to the best of our knowledge, there is no research that has yet applied ML to develop predictive models for biomolecular crystallization. Therefore, the key focus of this perspective is to demonstrate how ML approaches can be effectively applied to crystallization processes. While biomolecules and small molecules may have different properties and variables to predict, once sensor data are collected and transformed into a data array, the application of machine learning techniques becomes fundamentally similar from a mathematical point of view. Specifically, we start with a brief introduction to various types of ML methods and provide a review of the applications of AI and ML to crystallization. AI and ML have become increasingly important in improving our understanding of biomolecular crystallization, offering new insights and predictive capabilities that were previously unattainable. Subsequently, we introduce three ML approaches to address practical implementation issues in the context of modeling the crystallization processes. Two examples of crystallization processes are presented to demonstrate the effectiveness of the proposed ML algorithms.

Indexed as

Artificial IntelligenceMachine LearningAlgorithmsCrystallizationPrediction AlgorithmsPredictive Learning ModelsSoft ComputingArtificial intelligenceCrystallizationMachine learningModel predictive controlProcess modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.